EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics

Ganesh S Kakde, Tikam Chand Dakal, Pawan Kumar Maurya

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189540 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Ganesh S Kakde und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Central University of Haryana, Mahendergarh 123031, Haryana, India. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Glioblastoma, Metabolomics, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 156 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most malignant form of primary brain tumor in adults, described by profound molecular heterogeneity, rapid progression, and limited therapeutic response. Despite advances in chemotherapy (TMZ), radiotherapy, and surgery, patient outcomes remain poor, with a median survival of 12-15 months. Traditional single-omics studies have identified critical biomarkers such as IDH mutations, MGMT promoter methylation, and EGFR alterations; however, these provide only partial insight into the disease's complexity. Recent integrative multi-omics approaches encompassing genomics, transcriptomics, epigenomics, proteomics, metabolomics, and non-coding RNAs have transformed the landscape of biomarker discovery in GBM. Genomic profiling has revealed recurrent mutations and subtype-specific aberrations, while transcriptomic analyses refine molecular classification and uncover alternative splicing and fusion events. Epigenomic markers, particularly MGMT methylation and G-CIMP status, are now central to prognosis and therapy stratification. Proteomic and metabolomic studies highlight dysregulated pathways, metabolic vulnerabilities, and non-invasive biomarkers in cerebrospinal fluid and plasma. Integrating multi-omics data not only improves diagnostic and prognostic accuracy but also unveils therapeutic targets, offering opportunities for precision oncology. Furthermore, liquid biopsy and single-cell/spatial omics enhance real-time monitoring of disease progression and treatment response, addressing challenges posed by intratumoral heterogeneity. This review synthesizes recent advances in GBM biomarker research across multiple omics layers, emphasizing their complementary roles in unravelling tumor biology, guiding personalized treatment, and shaping future therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorGlioblastomaMetabolomicsBrain NeoplasmsGenomicsHumansMultiomicsProteomicsPrognosisDNA MethylationMutation

Stichwörter der Autor:innen

BiomarkersBrain CancerGlioblastomaMulti-omicsMutationsPersonalized therapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biochemistry, Central University of Haryana, Mahendergarh 123031, Haryana, India.
  • Genome and Computational Biology Lab, Mohanlal Sukhadia University, Udaipur 313001, Rajasthan, India.
  • Department of Biochemistry, Central University of Haryana, Mahendergarh 123031, Haryana, India. Electronic address: pkmaurya@cuh.ac.in.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Kakde, G. S., Dakal, T. C., & Maurya, P. K. (2026). Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189540

Vancouver

Kakde GS, Dakal TC, Maurya PK. Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189540

BibTeX
@article{Kakde2026,
  author = {Kakde, Ganesh S and Dakal, Tikam Chand and Maurya, Pawan Kumar},
  title = {Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189540}
}
Kostenlos starten →